Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera’s First Program With Regeneron Advances In Preclinical Development

Nov 2 (Reuters) - 
  
    * ABCELLERA’S FIRST PROGRAM WITH REGENERON IN MULTI-TARGET
COLLABORATION ADVANCES IN PRECLINICAL DEVELOPMENT

Source text for Eikon:  ID:nBw3QMkga 
Further company coverage: [ ]
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AbCellera Biologics

See all news